Chemical industry – Page 56
-
Business
Fertiliser firms Agrium and PotashCorp to merge
Canadian combination will create one of the largest crop nutrient companies in the world.
-
Business
Bayer to buy seed giant Monsanto
$66bn deal follows agrochemical consolidation trend, but could threaten competition and hit R&D
-
Business
Atanor chemical plant in Argentina shuttered
Toxic releases have led to the indefinite closure of the facility after a decade-long legal fight
-
Business
Brexit could push Japanese pharma out of the UK
Warnings that Japanese R&D investment in the UK is endangered by plans to leave the EU
-
Business
Sadara cracker eyes richer chemical rewards
Joint venture between Dow and Saudi Aramco will target added value plastics and speciality chemicals
-
Business
Healthcare firms invest in Crispr gene editing technology
Crispr licence agreements open up opportunities in drug discovery
-
Business
Novartis reshuffle puts 120 staff at risk
Commitment to gene and cell therapy treatments emphasised as unit broken up amid pharmaceutical division refocus
-
Business
US government agency awards Monsanto whistleblower $22 million
Pay-out is second largest reward from US whistleblower programme
-
Business
Joined-up thinking
The rift between contract medicinal chemistry and chemical development needs to be bridged
-
Opinion
Don’t fear the Crispr
Does simple gene-editing mean the end of traditional medicinal chemistry? Probably not
-
Business
Fatal incidents at two chemical plants
In recent weeks three people have been killed in chemical plant accidents in Malaysia and the US
-
Business
FDA urges labs to test all blood donations for Zika
Agency has also given emergency authorisation to two new Zika blood tests
-
Business
Pfizer to buy Astrazeneca’s antibiotics
Deal tops up Pfizer’s late-stage development pipeline, but AZ will retain biological programmes
-
Business
Pfizer gambles on $14bn Medivation deal
Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
-
Research
Membranes promise to slash energy needed to separate hydrocarbons
ExxonMobil-backed study allows reverse osmosis of hard-to-distinguish para-xylene and ortho-xylene
-
Business
EU examines Dow–DuPont union
European commission probes competition implications of the planned mega-merger
-
Business
On the innovation horizon
Bringing disruptive technology to market requires enhanced collaboration
-
Opinion
How do companies deal with political shifts?
Political instability hits small companies hardest